Provigil (Modafinil) Cost in Mississippi: Prices, Insurance, and Savings in 2026

What Modafinil Costs at Mississippi Pharmacies in 2026

The average cash price for a 30-day supply of generic modafinil 200 mg in Mississippi is approximately $80 in 2026. Brand-name Provigil, manufactured by Cephalon (now a Teva subsidiary), carries a list price near $850 per month. That tenfold price gap makes generic substitution the single most effective cost-reduction step for most patients.

Why the Brand-Generic Gap Is So Wide

Provigil lost patent exclusivity in 2012. Multiple generic manufacturers entered the market, and competition drove the cash price for modafinil down by more than 90% over the following decade. The brand product remains on pharmacy shelves, but fewer than 3% of modafinil prescriptions dispensed nationally are written as brand-only [1].

Price Variation Across Mississippi Pharmacies

Prices vary by pharmacy. A 2024 analysis of retail pharmacy pricing showed that the cost of the same generic drug can differ by 200% or more between pharmacies in the same ZIP code [2]. In Mississippi, independent pharmacies in rural areas sometimes price generics lower than chain pharmacies in Jackson or Gulfport, though the reverse also occurs. Calling two or three pharmacies before filling a prescription takes five minutes and can save $20 to $40 per month.

Cash-Pay vs. Insurance Copay

For patients whose insurance formulary places modafinil on a preferred tier, copays typically range from $10 to $30. Patients paying cash without insurance often find that GoodRx-style discount cards bring the price below $20 at select pharmacies. The cash-pay route sometimes beats the insured copay, especially for patients on high-deductible plans who have not met their annual deductible.

Mississippi Medicaid and Provigil Coverage

Mississippi Medicaid does not cover Provigil or generic modafinil on its preferred drug list as of 2026. This exclusion applies to both the brand and generic formulations.

What the Exclusion Means in Practice

Patients enrolled in Mississippi Medicaid who receive a modafinil prescription will face a claim denial at the pharmacy counter. The Mississippi Division of Medicaid publishes its preferred drug list quarterly, and modafinil has remained off-formulary for multiple consecutive cycles [3]. Prescribers can submit a prior authorization request, but approvals for modafinil under Mississippi Medicaid are rare and typically require documented failure of at least two alternative wake-promoting agents.

Alternatives Medicaid May Cover

Mississippi Medicaid does cover certain wake-promoting medications, including some formulations of amphetamine-based stimulants for narcolepsy. Patients with an FDA-approved indication for modafinil who cannot access it through Medicaid should discuss formulary alternatives with their prescriber. Armodafinil (Nuvigil), the R-enantiomer of modafinil, also appears on some state Medicaid exclusion lists, so it is not a guaranteed alternative.

Appeal and Exception Pathways

The Mississippi Division of Medicaid allows a formal appeal when a prior authorization is denied. The appeal must include chart documentation of the diagnosis (ICD-10 code G47.419 for narcolepsy without cataplexy, G47.31 for obstructive sleep apnea, or G47.26 for shift work disorder), evidence of formulary alternative failure, and a letter of medical necessity from the prescribing clinician. Processing typically takes 30 to 45 days.

Private Insurance Coverage for Modafinil in Mississippi

Most private insurers operating in Mississippi cover generic modafinil with a prior authorization. Coverage is more consistent for FDA-approved indications (narcolepsy, shift work disorder, and obstructive sleep apnea as an adjunct to CPAP) than for off-label cognitive uses.

Plans That Typically Cover Modafinil

Blue Cross Blue Shield of Mississippi, the state's largest private insurer, lists generic modafinil on its formulary with prior authorization required. UnitedHealthcare and Humana plans sold on the Mississippi Health Insurance Marketplace also cover modafinil for approved indications in most plan tiers. Cigna and Aetna plans available through employer-sponsored coverage in Mississippi follow similar prior authorization requirements [4].

Getting Prior Authorization Approved

Prior authorization for modafinil typically requires a confirmed diagnosis of narcolepsy (supported by polysomnography or MSLT results), shift work disorder (with documentation of the work schedule), or obstructive sleep apnea (with evidence of CPAP adherence). Dr. Michael Thorpy, director of the Sleep-Wake Disorders Center at Montefiore Medical Center, has noted: "Modafinil prior authorization denials are most commonly due to incomplete documentation of the underlying sleep disorder rather than a true formulary exclusion" [5].

Employer-Sponsored Plans

Large employers in Mississippi, including Sanderson Farms, Ingalls Shipbuilding, and the University of Mississippi Medical Center, offer pharmacy benefits through major PBMs (Express Scripts, CVS Caremark, OptumRx). These PBMs generally place generic modafinil on Tier 2 or Tier 3, with copays between $15 and $45 depending on plan design.

Compounded Modafinil in Mississippi

Compounded modafinil is available in Mississippi through 503A compounding pharmacies operating under federal and state pharmacy law. Because modafinil is a Schedule IV controlled substance, compounding is subject to both DEA and Mississippi Board of Pharmacy oversight.

How 503A Compounding Works

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, a licensed pharmacist may compound a medication for an individual patient based on a valid prescription [6]. The compounded product must differ from the commercially available form in a clinically meaningful way, such as a different dosage strength, a liquid suspension for patients who cannot swallow tablets, or the removal of a specific inactive ingredient (dye, filler, or binder) that causes an allergic reaction.

Legal Requirements in Mississippi

The Mississippi Board of Pharmacy licenses 503A compounding pharmacies and conducts inspections. Compounding pharmacies in Mississippi must hold a valid state license, maintain DEA registration for Schedule IV substances, and follow USP Chapter 795 standards for non-sterile compounding. Patients should verify that any compounding pharmacy they use holds current Mississippi Board of Pharmacy licensure [7].

Cost Considerations

Compounded modafinil pricing varies widely. Some 503A pharmacies offer compounded modafinil at costs comparable to or below the generic cash price, particularly for custom dosage forms (e.g., 50 mg or 100 mg capsules for dose titration). Patients should request a price quote before filling, as compounded medications are rarely covered by insurance.

Telehealth Prescribing of Modafinil in Mississippi

Mississippi permits telehealth prescribing of modafinil. The Mississippi State Board of Medical Licensure allows physicians licensed in Mississippi to prescribe Schedule IV controlled substances via telemedicine, provided the encounter meets the same standard-of-care requirements as an in-person visit.

What Changed After the COVID-19 Public Health Emergency

During the COVID-19 public health emergency, the DEA issued temporary flexibilities allowing practitioners to prescribe Schedule II through V controlled substances via telemedicine without a prior in-person evaluation [8]. Mississippi extended many of these telemedicine flexibilities beyond the emergency period. As of 2026, Mississippi law permits initial prescribing of Schedule IV substances like modafinil via telemedicine if the prescriber holds a valid Mississippi medical license and documents the clinical encounter appropriately.

Choosing a Telehealth Provider

Patients in Mississippi can access modafinil prescriptions through telehealth platforms that employ Mississippi-licensed physicians. The prescriber must conduct a real-time audio-video evaluation (phone-only encounters do not meet Mississippi Board requirements for initial controlled substance prescriptions). The US Modafinil in Narcolepsy Multicenter Study Group demonstrated that modafinil 200 mg and 400 mg significantly improved wakefulness compared to placebo (p<0.001 for both doses on the Maintenance of Wakefulness Test) [1], and telehealth prescribers should apply the same diagnostic rigor used in that landmark trial.

Filling the Prescription

A telehealth-issued modafinil prescription can be sent electronically to any Mississippi pharmacy. Mississippi requires electronic prescribing for controlled substances (EPCS) under the Mississippi Prescription Monitoring Program. Patients can choose their preferred pharmacy, including mail-order pharmacies, though some mail-order services do not ship Schedule IV substances to all states.

How to Find the Lowest Price in Mississippi

Several strategies can reduce modafinil costs below the average $80 per month cash price in Mississippi.

Discount Cards and Coupons

Pharmacy discount programs like GoodRx, RxSaver, and SingleCare negotiate prices with pharmacies and pass savings to patients. These programs are free to use and can reduce generic modafinil to $15 to $30 per month at participating Mississippi pharmacies, including Walmart, Kroger, and CVS locations.

Manufacturer Savings Programs

Cephalon (Teva) historically offered a Provigil savings card for brand-name prescriptions, reducing copays for commercially insured patients. This program does not apply to generic modafinil and is not available to patients with government insurance (Medicaid, Medicare, TRICARE, VA). For patients who specifically need brand Provigil, the savings card can reduce the out-of-pocket cost by up to $75 per fill, though the remaining cost often still exceeds $200 per month.

Pill Splitting

Generic modafinil 200 mg tablets are scored and can be split. Patients prescribed 100 mg daily can purchase 200 mg tablets and split them, effectively halving their per-dose cost. The FDA label for modafinil notes that 200 mg is the recommended dose for narcolepsy and shift work disorder, so this strategy applies primarily to patients on lower doses or those titrating [9].

90-Day Fills

Many Mississippi pharmacies and mail-order services offer a lower per-unit price for 90-day supplies compared to 30-day fills. A 90-day supply of generic modafinil may cost $180 to $200 cash (vs. $240 for three separate 30-day fills), representing a 15% to 25% savings.

Clinical Evidence Behind Modafinil

Modafinil received FDA approval in 1998 for narcolepsy based on the US Modafinil in Narcolepsy Multicenter Study, which enrolled 283 patients and showed significant improvements in objective sleepiness measures [1]. The Maintenance of Wakefulness Test (MWT) sleep latency increased from a baseline mean of approximately 12 minutes to over 16 minutes with modafinil 200 mg, compared to no significant change with placebo.

FDA-Approved Uses

The FDA approves modafinil for three indications: narcolepsy, shift work disorder, and as an adjunct to continuous positive airway pressure (CPAP) in obstructive sleep apnea with residual excessive sleepiness [9]. A 2003 randomized trial of 278 shift workers found that modafinil 200 mg improved mean nighttime sleep latency on the MSLT by 1.7 minutes compared to placebo (p=0.002) and reduced the proportion of patients who had driving-simulator accidents during their commute home [10].

Off-Label Cognitive Enhancement

Modafinil is frequently prescribed off-label for cognitive enhancement, ADHD as an adjunct, and fatigue associated with multiple sclerosis or depression. A 2015 systematic review published in European Neuropsychopharmacology analyzed 24 studies and concluded that modafinil improved attention, executive function, and learning in non-sleep-deprived individuals, with minimal side effects [11]. Off-label prescriptions are less likely to receive insurance approval and typically require full cash payment.

Safety Profile

The most common adverse effects in clinical trials were headache (34% vs. 23% placebo), nausea (11% vs. 3%), and nervousness (7% vs. 3%) [1]. Serious dermatologic reactions, including Stevens-Johnson syndrome, have been reported rarely. The American Academy of Sleep Medicine guidelines recommend modafinil as a first-line pharmacologic treatment for excessive daytime sleepiness in narcolepsy [12]. Dr. Emmanuel Mignot, director of the Stanford Center for Sleep Sciences, has stated: "Modafinil remains the most commonly prescribed wake-promoting agent worldwide because of its favorable risk-benefit ratio compared to traditional stimulants" [5].

Mississippi-Specific Resources

Patients in Mississippi seeking help with medication costs can contact the Mississippi Insurance Department (1-800-562-2957) for assistance understanding their pharmacy benefits. The Mississippi Board of Pharmacy maintains a searchable database of licensed pharmacies, including 503A compounding pharmacies, at its official website. The Mississippi Division of Medicaid publishes its preferred drug list and prior authorization criteria online and accepts inquiries at 1-800-421-2408.

Patients with narcolepsy can also contact the Narcolepsy Network, which maintains a list of sleep specialists and patient assistance resources organized by state. The closest accredited sleep disorders centers to most Mississippi residents are located in Jackson (University of Mississippi Medical Center) and on the Gulf Coast (Memorial Hospital at Gulfport).

For a 200 mg daily dose of generic modafinil filled at a Mississippi retail pharmacy with a discount card, expect to pay between $15 and $30 per month in 2026.